ATS Research Program: Partnership Grants

ABOUT

In late 2002, when the ATS Board of Directors voted unanimously to create a new Research Program, the Society was further enhancing its strong commitment to the ideals of research. Since that historical moment, the ATS Research Program has steadily grown and continues to thrive. The Research Program operates under the critical guiding principles of partnership and collaboration. From the genesis of the Program, the ATS realized that maximal progress could be made in research if the Society worked in harmony with other organization focusing on the diagnosis, pathogenesis and treatment of lung disease.

OUR RESEARCH PROGRAM PARTNERS

The Research Program operates under the intention that the ATS will set research priorities and share funding responsibilities with other medical, research, clinical, professional, corporate, patient and nonprofit health organizations with interest in pulmonary and critical care disease and disorders. Our current research partners are:

Aerocrine, Inc.
Alpha-1 Foundation*
American Lung Association of Oregon
ATS Foundation Tobacco-Dependence Research Funds
chILD Foundation
chILD (Lung) Foundation –UK
Coalition for Pulmonary Fibrosis
Emphysema Fighting for Our Right to Survive (EFFORTS)
Foundation for Sarcoidosis Research
Hermansky-Pudlak Syndrome Network
Merck, Inc.
The Nathan Cummings Foundation
Pfizer, Inc.
Pulmonary Fibrosis Foundation
Pulmonary Hypertension Association*
Respiratory Health Association of Metropolitan Chicago

* These organizations are members of the ATS Public Advisory Roundtable

To read more about the ATS Research Program, please click here.